Kezar Life Sciences
KZR
KZR
136 hedge funds and large institutions have $188M invested in Kezar Life Sciences in 2023 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 51 increasing their positions, 39 reducing their positions, and 17 closing their positions.
Holders
136
Holders Change
+13
Holders Change %
+10.57%
% of All Funds
2.18%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
30
Increased
51
Reduced
39
Closed
17
Calls
$2.91M
Puts
$2.36M
Net Calls
+$547K
Net Calls Change
-$918K
Top Buyers
| 1 |
SCM
1
Suvretta Capital Management
New York
|
$21.6M |
| 2 |
PM
2
Prosight Management
Dallas,
Texas
|
$10M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$3.02M |
| 4 |
O
4
OrbiMed
New York
|
$17.1M |
| 5 |
5
Barclays
London,
United Kingdom
|
$2.59M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
DU
151
Delphia (USA)
Toronto,
Ontario, Canada
| – | -$71.4K | -1,014 | Closed |
|
152
Allspring Global Investments
Charlotte,
North Carolina
| – | -$15.8K | -224 | Closed |
|
|
FGAM
153
Financial Gravity Asset Management
Lakeway,
Texas
| – | -$129 | -1 | Closed |
|